Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2008 17:57 ET | Source: MicroIslet, Inc.

MicroIslet Announces Voluntary Reorganization Filing

SAN DIEGO, Nov. 10, 2008 (GLOBE NEWSWIRE) -- MicroIslet Inc. (OTCBB:MIIS) (http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for...
November 16, 2007 08:30 ET | Source: MicroIslet, Inc.

MicroIslet Completes a $1 Million Private Placement

SAN DIEGO, Nov. 16, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) is a biotechnology company engaged in the development and commercialization of encapsulated islet cells for transplantation...
October 15, 2007 09:00 ET | Source: MicroIslet, Inc.

MicroIslet Announces the Appointment of Amaresh Basu, Ph.D. as Vice President, Research and Development, and the Retention of Regulus Pharmaceutical Consulting

SAN DIEGO, Oct. 15, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) announced today that Amaresh Basu, Ph.D. has been named Vice President, Research and Development. Separately, MicroIslet...
September 26, 2007 08:35 ET | Source: MicroIslet, Inc.

Barry Ritholtz, Noted Stock Market Analyst, Appointed to the Board of Directors of MicroIslet

SAN DIEGO, Sept. 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Barry Ritholtz has been named to the Company's Board of Directors. "I am very excited...
September 21, 2007 09:30 ET | Source: MicroIslet, Inc.

MicroIslet Receives $1 Million Working Capital Loan

SAN DIEGO, Sept. 21, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS), a development-stage biotechnology company with patented and proprietary technologies focused on transplantation therapy for...
September 17, 2007 10:05 ET | Source: MicroIslet, Inc.

MicroIslet and Progenitor Cell Therapy Enter Into Agreement for the Manufacturing of MicroIslet-P, an Encapsulated Islet Cell Product for the Treatment of Type 1 Diabetes

SAN DIEGO and HACKENSACK, N.J., Sept. 17, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS), a development-stage biotechnology company with patented and proprietary technologies focused on...
August 21, 2007 09:30 ET | Source: MicroIslet, Inc.

MicroIslet, Inc. Files Quarterly Report On Form 10-QSB for Second Quarter 2007

SAN DIEGO, Aug. 21, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) announced that it filed its Quarterly Report on Form 10-QSB for the quarter ended June 30, 2007, with the Securities and...
July 23, 2007 09:00 ET | Source: MicroIslet, Inc.

MicroIslet Implements Staffing Changes to Further the Company's New Corporate Strategy

SAN DIEGO, July 23, 2007 (PRIME NEWSWIRE) -- As previously announced, MicroIslet, Inc. (OTCBB:MIIS) (the "Company") has refocused its efforts to accelerate the clinical testing of the Company's...
July 05, 2007 14:40 ET | Source: MicroIslet, Inc.

Jonathan Lakey, Co-Developer of the Edmonton Protocol, Named President, and Michael J. Andrews Appointed Chief Executive Officer of MicroIslet

SAN DIEGO, July 5, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Jonathan R.T. Lakey, Ph.D., M.S.M., has been named as President of MicroIslet, and...
June 26, 2007 12:34 ET | Source: MicroIslet, Inc.

Edmonton Protocol Diabetes Islet Cell Pioneer Named Chief Scientific Officer of MicroIslet

SAN DIEGO, June 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Jonathan R. T. Lakey, Ph.D., M.S.M., was named the Company's Chief Scientific Officer...